64.7% of Respondents Reported Eventually Quitting GLP-1s 64.7% of participants in our study reported eventually quitting the use of GLP-1 medications
Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Most Doubt the Trump Administration Will Lower Drug Costs for People Like Them, Though Three-Fourths of Republicans Expect It Will About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds
in the field of Neuroscience and Mental Health
The clinical trials used 4-week intervals at each level
Tier placement is based on current health status, not desired speed of results
The KFF survey findings are based on responses that were collected from a nationally representative sample of nearly 1,500 adults during the last week of April